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Psoriatic arthritis (PsA) is a chronic disease 
characterized by a form of inflammation of the skin 
(psoriasis)   and   joints   (arthritis).[1]   Its   features  are 
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patchy, raised, red areas of skin inflammation with 
scaling. Psoriasis often affects posterior of the elbows 
and anterior aspect of knees, scalp, ear and navel, 
lumbo-sacral and around the genital areas or anus. 
Approximately 10% of patients who have psoriasis 
also develop an associated inflammation of their 
joints. Patients who have inflammatory arthritis and 
psoriasis are diagnosed as having psoriatic arthritis.[2]  
The onset of psoriatic arthritis generally occurs in the 
fourth and fifth decades of life. Males and females are 
affected equally. The skin disease (psoriasis) and the 
joint disease (arthritis) often appear separately. In 60–
70% of cases, psoriasis precedes joint disease. In 
about 15–20% of cases, the arthritis precedes the 
onset of psoriasis and can present a diagnostic 
A B S T R A C T  
Background: Arthritis and various musculoskeletal disorders are the leading cause of disability in persons 
between 18 to 65 years of age. Psoriatic arthritis simulates Ayurvedic descriptions of the clinical syndrome - 
Vatarakta. The study has been designed to evaluate the effectiveness of classical Ashtavaidyan methods of 
Ayurvedic intervention in the management of psoriatic arthritis and to assess the safety of the therapy. 
Methodology:  Diagnosed cases of psoriatic arthritis (n=30) (20-60 yrs) have undergone the prescribed 
classical Ashtavaidyan Ayurvedic therapies. The total study period was 57 days which included 21 days each 
at inpatient and outpatient basis and 15 days of follow up. Initially modified Takradhara was performed 
along with internal medications for first 14 days; later same internal medication was continued with 
Sarvanga Abhyanga (therapeutic massage) with Pinda  Taila  and Vajraka Ghrita in 3:1 ratio externally and 
Amalaki Thalam for next 7 days.  Same internal medicines and oil application were continued for next 21 
days as outpatient. Results: The response to treatment was assessed periodically with respective 
parameters and showed highly significant improvement (P<0.001). There was significant reduction in PASI 
score and also significant changes in functional parameters related to psoriatic arthritis evaluated by using 
the visual analogue pain scale, DAS score, disability index scores and SF-36 (quality of life Index). The 
laboratory parameters used to evaluate the liver and renal functions did not show any significant changes 
that indicate the prescribed treatment is safe. Conclusion: Traditional Ashtavaidyan Ayurveda therapy is 
effective in reducing the skin lesions and improving functional ability in Vatarakta vis-à-vis psoriatic arthritis 
over a period of 42 days. Moreover, there was no adverse drug reaction recorded as well no significant 
change observed in liver and renal function tests. 
Key words: Ayurveda, Psoriatic Arthritis, Vatarakta, Takradhara, Functional Improvement, Vajraka Ghrita. 
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challenge. Pain, swelling, or stiffness in one or more 
joints is commonly present in psoriatic arthritis.[3]  
The cause of psoriatic arthritis is not clearly known 
but combination of genetic, immune and 
environmental factors are likely to be involved.[4] The 
estimates of the prevalence of psoriatic arthritis 
among individuals with psoriasis range from 5 to 
30%.[5] the diagnosis of PsA is primarily clinical, based 
on the presence of psoriasis and characteristic 
symptoms of joint involvement.[6]  
Non-steroidal anti-inflammatory drugs constitute the 
mainstay of pharmacological therapy for most 
patients. Early use of methotrexate, is indicated in 
patients with a poor response to NSAIDs or those with 
polyarticular and progressive joint involvement.[7]  
In Ayurveda symptomatology of psoriatic arthritis can 
be correlated to the reference of Vatarakta in a 
broader sense. The characteristic feature of psoriatic 
arthritis, skin disease precedes the arthritis, can be 
observed in Uthana and Gambeera stages of  
Vatarakta, where in Sushruta Samhitha Chikitsa 
Sthana, it is explained that the disease Vatarakta  first 
manifest as Uthana type with cutaneous 
manifestations and on passing of time it affects the 
deeper Dhatu ( tissue) and form the Gambheera 
Vatarakta.[8] In Uthana Vatarakta, the disease activity 
and clinical features are confined to Twak (skin) and 
Mamsa Dhatu (muscle) causing symptoms such as 
Kandu (itching), Daha (burning sensation), Ruja (pain), 
Toda, Akunchana, Bheda (different types of pain), 
Spurana (fasiculations), Gourava (heaviness), Suptata 
(numbness) and Syavata (discolouration), Raktatwak 
(redness of skin) which denotes painful joints 
associated with skin lesions.[9]  
The Purva Rupa (prodromata)of Vatarakta is same as 
the Kushta (skin disease) with the symptoms, Asweda 
(lack of sweating), Atisweda (excessive sweating), 
Sparshaghnata (numbness), Vaivarnyam 
(discoloration), Twak Parushyam (roughness of skin), 
associated with Sandhiruk (joint pain).[10] These 
symptoms involve both skin and joints which is 
observed in psoriatic arthritis. In Vatarakta, when 
Vata gets vitiated along with Rakta, it imparts such 
qualities as Rukshta and Laghuta to Rakta thereby 
bringing about the qualitative and quantitative 
changes in the Rakta Dhatu itself.[11] The vitiation of 
Vata and Rakta results in the deterioration of 
Prakruta Karma leading to Vaivarnya (discoloration) 
and Krishata, Sandhi Vedana (pain), Toda, Santapa 
(burning sensation) increased Kleda in the Rakta 
creates an atmosphere conducive to the occurrence 
of skin changes which can be justified by the 
treatments mentioned in Rakta / Pittadhika  
Vatarakta  such as Sheeta Pradeha / Seka, Virechana, 
Rakta Mokshana, Ghrita Ksheerapanam, and all the 
internal and external medicines and treatments that 
pacify the Rakta and Pitta.[12] 
In the present day living condition, incidence of 
psoriatic arthritis is increasing due to the improper 
food habits and stress and strain of various types. 
Since there is no satisfactory treatment in other 
systems for complete cure of this disease, the 
traditional practice of Ashtavaidyan line of 
management has been validated clinically in psoriatic 
arthritis to prove its safety and effectiveness  in 
scientific lines.     
METHODOLOGY 
The study was an open, single arm, clinical study. The 
setting of the study was inpatient (IP) and outpatient 
(OP) department levels of Vaidyaratnam Ayurveda 
Foundation, Centre of Excellence for Ayurvedic 
Management of Chronic Joint Disorders, Ollur, 
Thrissur, Kerala and The study was carried out 
between years 2011-2016 under Centre of Excellence 
for Ayurvedic Management of Chronic Joint Disorders 
scheme allotted by Ministry of AYUSH, Govt. of India. 
The clinical trial was approved by the Institutional 
Ethics Committee and the study was registered with 
the Clinical Trial Registry of India 
(CTRI/2018/09/015820). The protocol of the study 
and the case report form (CRF) was prepared as per 
the direction and suggestions by Central Council for 
Research in Ayurvedic Sciences, New Delhi. 
Patient selection 
Thirty participants of psoriatic arthritis patients 
satisfying the inclusion criteria were recruited to the 
Ashtavaidyan ET Neelakandhan Mooss et.al. Classical Ashtavaidyan Ayurvedic Therapy in Psoriatic Arthritis 
ISSN: 2456-3110                                                   ORIGINAL ARTICLE Mar-Apr 2019 
 
Journal of Ayurveda and Integrated Medical Sciences | Mar - Apr  2019 | Vol. 4 | Issue 2 47 
 
study. Those patients with multiple joints pain 
associated with complaints of psoriatic skin lesions 
and the nail changes were diagnosed as psoriatic 
arthritis. The age groups of patients selected were 
between 20-60 years. The patients who had 
secondary complications and long duration of the 
disease, steroid dependent, prolonged medications, 
other systemic disorders such as diabetes mellitus, 
essential hypertension, other arthritis like gout, osteo-
arthritis, rheumatic fever, rheumatoid arthritis, 
ankylosing spondylitis, gonorrheal / syphilitic arthritis, 
arthritis with malignancy, acute pyogenic arthritis, 
tubercular arthritis and  osteomyelitis  as well as 
pregnant and lactating women were excluded from 
the study.  
Informed consent was obtained from all the 
participants and detailed clinical examination was 
done based on case record form. During the course of 
treatment, the subjects who had developed any 
serious condition or any serious adverse events which 
requires urgent treatment or if patient himself want 
to withdraw from the study, were withdrawn from 
the trial. 








































































































The course of therapy included treatment both 
inpatient and outpatient level for a period of 21 days 
each. During initial course of 21 days of inpatient 
admission, Internal medicines were Manibhadra 
Leha[13] (10 gm) followed by Rasnerandadi Kashaya[14] 
(100 ml) at morning 6am and the same Kashaya with 
Kaishora Guggulu[15] tablet at evening 6 pm and 
Vajraka Ghrita[16] (10 gm) at 8 pm. Externally, from 1st-
14th day, Takradhara processed with Amalaki and 
Yashtimadhu was performed. From day 15 to 21st day, 
Sarvanga Abhyanga with Pinda  Taila [17] mixed with 
Vajraka Ghrita in the ratio of 3:1 and Asanavilwadi  
Taila [18] on scalp and Thalam with Amalaki Kalka 
were given, during IP treatment. The internal 
medicines were continued during 21 days of OP 
treatment and externally, Abhyanga was also advised. 
The raw materials of trial medicines were identified 
and authenticated and undergone strict quality 
control evaluation as per the guidelines described in 
Ayurvedic Formulary of India in the laboratory of 
CARE Keralam, Thrissur. Trial medicine was prepared 
in the Vaidyaratnam Oushadhasala Pvt. Ltd., Thrissur, 
Kerala which is GMP certified Ayurveda pharmacy.  
The assessment of result was made based on the 
scores provided to each signs and symptoms recorded 
periodically on 21st, 42nd and 57th day and compared 
the changes to the baseline. Laboratory investigations 
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were performed for all the patients at baseline and 
after the full course of the treatment. This includes 
haemogram, biochemical parameters namely blood 
glucose, serum cholesterol, uric acid, liver function 
test, renal function test, C-reactive protein and ASO 
titer and X-ray of affected joint. The functional 
parameters were recorded using the validated scales - 
visual analogue pain rating scale, DAS score, SF-36, 
disability index and global assessment scale.  
Statistical analysis was performed using SPSS version 
20; Friedman’s test and repeated measures ANOVA 
and details are given in the result section. 
OBSERVATIONS AND RESULTS 
Socio-demographic Profile 
Table 2: Socio-Demographic Characteristics of the 
Patients 
Characteristics Category Frequency Percent 
Gender Female 9 30.0 
Male 21 70.0 
Age group 
(yrs) 
Below 20 2 6.7 
21-30 7 23.3 
31-40 4 13.3 
41-50 11 36.7 
51-60 6 20.0 
Marital status Married 23 76.7 
Unmarried 7 23.3 
Educational 
status 
Illiterate 2 6.7 
Read and write 28 93.3 
Past 
Occupation 
Desk Work 11 36.7 
Field work with physical 
labor 
11 36.7 
Field work 6 20.0 
No Occupation 2 6.7 
Habitat Urban 5 16.7 
Semi-urban 17 56.7 
Rural 8 26.7 
Religion Hindu 25 83.3 
Christian 2 6.7 
Muslim 3 10.0 
The Deha Prakriti of patients were analysed using a 
special proforma and it indicate that the majority of 
patients belongs to Pitta-Kaphaja (53.3%) and 
Vatapittaja (40%) Prakriti. Sara analysis showed that 
majority were Rasa and Rakta Sara (23% each), 
Mamsa and Asthi Sara (20% each). The physiological 
characters such as Satmya, Satva, Ahara Shakti, 
Vyayama Shakti of patients were also assessed which 
showed majority of them belongs to Madhyama 
category. The assessment of Samhana falls in the 
group of Pravara type.  
Disease profile 
The majority of patients had an insidious onset 
(83.3%) and remaining 16.7 % was with acute onset. 
26.7% of participants were having a recent onset with 
less than 6 months duration and the rest were 
between 12- 60 months interval. In 66.7% of 
participants there was a previous history of illness. 
Aggravating factors are given in (Table 3). 
Table 3: Aggravating factors 
Factors Frequency Percentage 
Food 3 10.0 
Weather 17 56.7 
Food and weather 8 26.7 
Food, drink and weather 2 6.7 
RESULTS 
Effect on joint parameters 
The assessment of chief complaints at the baseline of 
treatments were pain in joints (100%), swelling in 
joints (86.7%) morning stiffness (93.3%) tenderness 
(96.7%) fever (23.3%), general weakness (96.7%) and 
skin lesion  (100%). Proportion test was used to 
compare the base line percentage to the percentage 
of reduction of each symptom at consecutive visits. 
Significant reduction was observed in all symptoms in 
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the first periodical assessment itself. The statistical 
evaluation of the chief complaints such as joint pain, 
swelling and skin lesions and other symptoms have 
got significant response with P< 0.01(Table 4).  
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Values within brackets are percentages; a significant at 0.01 level; 
ns non significant (Compared to base line) 
FUNCTIONAL PARAMETERS 
Effect on Joint pain 
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Pain score: Analysis of visual analogue pain score 
between different treatment intervals was made 
using Friedman’s test. A significant decrease was 
noted at 21st day and 42nd day compared to the 
baseline data. Number of joints affected were noted 
at the time of admission and in intervals of 21st, 42nd 
and 57th day and found that there was a significant 
reduction in the number of the affected joints 
(P<0.001) (Table 5).  
DAS score obtained at different measurement time 
were subjected to repeated measures ANOVA and 
results show that there is a significant reduction from 
the first day to 21st day. No significant difference was 
noted between day 21 and day 42.  
Disability index assessed at various treatment 
intervals were subjected to repeated measures 
ANOVA show that there is a significant reduction. 
(Table 5). 
Effect on psoriasis related parameters 
Comparison of PASI score among different time 
period was done and it was found that there was a 
significant decrease in PASI Score (P<0.001) from first 
day to 42nd day and then to 57th day.  (Table 5). 
Biochemical parameters 
The biochemical and hematological parameters 
namely ESR, CRP, Hb% were compared to the pre-
treatment period to that of post treatment results 
and it was observed that there was no significant 
change. This indicates that therapy is safe following 
the prescribed medications and therapy. 
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Table 6: Observation on Liver and Renal Function 
Tests 
















































































** Significant at 0.01 level; * significant at 0.05 level; ns - non 
significant  
Overall assessment of response of the course of 
treatment was noted by the physician and patient. 
From physician observation, it was found that 16.7% 
with complete (75-100%), 53.3% had good relief (50-
75%) and 4% partial (25-50%) relief. On patient’s 
assessment showed 26.7% complete relief, 70% good 
relief, and 3.3 % partial relief. Comparison of SF 36 
score in first day with that of 57th day was done by 
using paired t-test. Results show that there was 
significant reduction in SF-36 score in patient (Table 
7).  
Table 7: Comparison of SF- 36 Score 
Period Mean ± SE 
First day 217.457 ± 16.21 
57th day 665.82 ± 17.66 
t-value 18.966** 
P-value < 0.001 
 ** Significant at 0.01 level 
DISCUSSION 
As described earlier psoriatic arthritis can be 
compared with Vatarakta where the symptoms such 
as painful joints associated with swelling and skin 
lesions are the characteristic features. The 
Ashtavaidyan Ayurvedic line of treatment for the 
disease has been formulated according to the Dosha 
involvement. According to the classical reference the 
management of Vatarakta is stated as “Virechya 
Snehithvath Aadau Snehayukthe Virechanaihi, 
Ruksharva Mridubhi Shastham Asakruth 
Basthikarmam Cha, Seka Abhyanga Pradehan 
Snehaparyo Avidahinaha, Vatarakte Prashayante” [12] 
in Vatarakta patients initially advised oleation 
treatment followed by Snehayuktha Virechana but if 
patient is excessively unctuous then Mridu  Virechana 
with Rukshadravya (Tikshana Virechana should not be 
done because it creates Vataprakopa), later basti 
should be planned frequently followed by treatments 
like Seka, Abhyanga, food  and Sneha which do not 
cause burning sensation. 
The response of treatment was assessed by the 
changes observed in the parameters used for the 
assessment at fixed intervals. The signs and symptoms 
used as the criteria of assessment for the response of 
treatment at the periodical intervals were compared 
with the baseline and found that all the assessment 
parameters have significant positive changes. 
In the present protocol, Takradhara processed with 
Amalaki and Yashtimadhu was done externally for 2 
weeks followed by Abhyangam with Pinda  Taila  
mixed with Vajraka Ghrita. Adding of Pinda  Taila  
with Vajraka Ghrita has special indication in psoriasis 
associated with arthritis. Internal administration of 
Manibhadra Leha has been advocated in Kushta (skin 
disease) and Raktaja Vikara. This acts like Nitya 
Shodana for the skin ailments. Rasnaerandadi 
Kashaya mixed with Kaishora Guggulu tablet has 
specific effect in treating psoriatic arthritis and widely 
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used in Ayurvedic practice in Kerala. Kaishora Guggulu 
is specifically mentioned for Kushta, Tridoshaja 
Vatarakta. Use of Vajraka Ghrita internally at 
bedtime, also have significant action in Raktapittaja 
conditions and special indication in Kushta (skin 
disease). The Asanavilwadi  Taila  was used for 
Shiroabhyanga which is generally prescribed for all 
the Raktaja and Pittaja Vikara. 
The report of the laboratory investigations including 
liver and renal function tests were compared before 
and after treatment and observed that there is no 
significant difference in the values which is an 
indication of the safety of the treatment. There were 
no adverse drug reaction reported during the course 
of therapy.  
CONCLUSION 
The clinical study clearly indicates that the prescribed 
classical Ashtavaidyan Ayurveda line of treatment is 
effective in the management of psoriatic arthritis 
(Vatarakta). The treatment has shown significant 
improvement in the functional ability of the patients. 
Moreover, the biochemical parameters to evaluated 
the changes in liver and kidney function did not show 
any significant variations. This indicates that the 
therapy is safe without producing any complication or 
adverse drug reaction. 
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